arrow
D

Damiano Paolicelli

University of Bari Aldo Moro
H指数:38
被引数:5,123

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validation of generative artificial intelligence techniques for synthetic data generation in multiple sclerosis research: A comparison with real-world evidence from the Italian multiple sclerosis registry

生成式人工智能技术在多发性硬化症研究中合成数据生成中的验证:与意大利多发性硬化症登记处真实世界证据的比较

2026-10-140
PRE
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study)

评估接受不同治疗方案序列治疗的视神经脊髓炎患者队列中长期严重不良事件风险的概况:意大利视神经脊髓炎及相关疾病登记研究(I-MS&RD)(ProSA研究)结果

2026-07-040
PRE
Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort

偏头痛间期负担量表(MIBS-4)在意大利临床队列中的翻译与验证

2026-04-170
OAAI
Impact of cladribine tablets on PROs in patients with MS: insights from the 1st interim analysis of the CLADFIT-MS study

克立屈滨片对多发性硬化患者结局的影响:来自CLADFIT-MS研究首次中期分析的见解

2026-04-110
OA
Effectiveness, safety, and impact on multiple sclerosis course of anti-CGRP monoclonal antibodies
2025-02-011
PRE
Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project
2024-08-020
OAAI
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis

那他珠单抗和ocrelizumab对多发性硬化疾病进展的比较

2024-07-053
OA
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study

那他珠单抗治疗继发性进行性多发性硬化的长期疗效: 一项倾向匹配研究

2024-07-011
OAAI
An Internet- and Kinect-Based Multiple Sclerosis Fitness Intervention Training With Pilates Exercises: Development and Usability Study

基于互联网和Kinect的多发性硬化症健身干预训练与普拉提练习: 开发和可用性研究

2023-11-081
OAAI